Respiri Past Earnings Performance

Past criteria checks 0/6

Respiri has been growing earnings at an average annual rate of 4.1%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been declining at an average rate of 17.2% per year.

Key information

4.1%

Earnings growth rate

14.7%

EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth rate-17.2%
Return on equity-181.3%
Net Margin-808.5%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Respiri Limited's (ASX:RSH) CEO Will Probably Find It Hard To See A Huge Raise This Year

Nov 08
Respiri Limited's (ASX:RSH) CEO Will Probably Find It Hard To See A Huge Raise This Year

We're Keeping An Eye On Respiri's (ASX:RSH) Cash Burn Rate

Aug 17
We're Keeping An Eye On Respiri's (ASX:RSH) Cash Burn Rate

Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn Situation

Apr 29
Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn Situation

Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn Situation

Jan 03
Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn Situation

Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn Situation

Sep 21
Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn Situation

We Think Respiri (ASX:RSH) Can Afford To Drive Business Growth

Jun 07
We Think Respiri (ASX:RSH) Can Afford To Drive Business Growth

Respiri (ASX:RSH) Is In A Good Position To Deliver On Growth Plans

Feb 22
Respiri (ASX:RSH) Is In A Good Position To Deliver On Growth Plans

Revenue & Expenses Breakdown
Beta

How Respiri makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:RSH Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 231-670
30 Sep 231-660
30 Jun 231-660
31 Mar 231-661
31 Dec 221-651
30 Sep 221-651
30 Jun 221-761
31 Mar 221-761
31 Dec 211-871
30 Sep 211-981
30 Jun 211-11101
31 Mar 211-12111
31 Dec 201-12121
30 Sep 202-1092
30 Jun 202-772
31 Mar 202-763
31 Dec 192-754
30 Sep 192-854
30 Jun 191-854
31 Mar 191-744
31 Dec 181-634
30 Sep 181-433
30 Jun 181-322
31 Mar 181-221
31 Dec 172-121
30 Sep 171-221
30 Jun 171-321
31 Mar 171-321
31 Dec 161-321
30 Sep 161-421
30 Jun 161-421
31 Mar 160-522
31 Dec 150-513
30 Sep 150-523
30 Jun 150-523
31 Mar 150-633
31 Dec 140-643
30 Sep 140-863
30 Jun 140-1074
31 Mar 140-1074
31 Dec 130-1073
30 Sep 130-853
30 Jun 130-642
31 Mar 130-532

Quality Earnings: RSH is currently unprofitable.

Growing Profit Margin: RSH is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: RSH is unprofitable, but has reduced losses over the past 5 years at a rate of 4.1% per year.

Accelerating Growth: Unable to compare RSH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: RSH is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: RSH has a negative Return on Equity (-181.29%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.